MedPath

Bronchodilator Test in Mechanical Ventilated Chronic Obstructive Pulmonary Disease Patients

Not Applicable
Conditions
Chronic Obstructive Pulmonary Disease
Interventions
Registration Number
NCT02218398
Lead Sponsor
Beijing Chao Yang Hospital
Brief Summary

Investigators developed a test to assess the bronchodilator effects in mechanically ventilated chronic obstructive pulmonary disease patients by comparing the change of airway resistance. No matter whether patients respond to bronchodilator or not, they are randomized assigned to bronchodilator 3-4 times per day group and no bronchodilator group. Then investigators could objectively decide whether individual patients need or benefit from bronchodilator administration.

Detailed Description

Bronchodilator is commonly used in mechanical ventilated chronic obstructive pulmonary disease patients. It is assumed that patient's response to bronchodilator is the same during acute exacerbation or when stable whether on mechanical ventilation or not. Decision to treat is often independent of response and the patient's response to the medicine is not precisely evaluated. Investigators developed a test to assess the bronchodilator effects in mechanically ventilated chronic obstructive pulmonary disease patients by comparing the change of airway resistance. No matter whether patients respond to bronchodilator or not, they are randomized assigned to bronchodilator 3-4 times per day group and no bronchodilator group. Then investigators could objectively decide whether individual patients need or benefit from bronchodilator administration.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
120
Inclusion Criteria

should meet all the criteria:

  1. Acute exacerbated chronic obstructive pulmonary disease
  2. Invasive mechanical ventilation with intubation outside ICU no more than 48 hours
Exclusion Criteria

Meet any of the criteria:

  1. Asthma
  2. Tracheotomy
  3. Prolonged Mechanical Ventilation (Have been mechanical ventilated for more than 21 days)
  4. Unstable hemodynamic status
  5. Severe pneumonia
  6. Contraindication for bronchodilator
  7. Contraindication for sedation
  8. Refusal to participate in study
  9. Re-intubation in 48 hours
  10. Mental disorder, could not understand and accomplish pulmonary function test

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
BronchodilatorAlbuterolAlbuterol 3-4 times per day, steroids when necessary.
Primary Outcome Measures
NameTimeMethod
Percentage of 12% Decrease in airway resistance30 minutes
Secondary Outcome Measures
NameTimeMethod
Duration of mechanical ventilationparticipants will be followed for the duration of ICU stay, an expected average of 28 days

Trial Locations

Locations (1)

Respiratory Intensive Care Unit, Beijing Chaoyang Hospital

🇨🇳

Beijing, Beijing, China

© Copyright 2025. All Rights Reserved by MedPath